| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Ubs Oncology Impact Fund L.P. is a 10% Owner at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 19 sells.
Estimated insider holdings value: $124.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 3,124 | $29.06 | $90,783.44 | - | -44.7% | -56.6% | |
| Sep 15, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 13,531 | $29.17 | $394,635.02 | - | -46.2% | -55.0% | |
| Sep 13, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 23,253 | $29.23 | $679,738.19 | -0.1% | -44.2% | -54.8% | |
| Sep 8, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 48,640 | $29.20 | $1,420,393.90 | -0.2% | -39.6% | -52.5% | |
| Sep 2, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 24,309 | $29.50 | $717,217.77 | - | -44.2% | -55.5% | |
| Aug 30, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 44,358 | $29.24 | $1,296,884.43 | -0.3% | -40.5% | -57.2% | |
| Aug 25, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 105,894 | $29.29 | $3,101,344.22 | -0.4% | -28.9% | -49.8% | |
| Aug 11, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Sell | 2,510 | $29.05 | $72,915.50 | - | -21.8% | -53.9% | |
| Jan 12, 2021 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Buy | 300,000 | $21.00 | $6,300,000.00 | +3.9% | - | - |